Robert A. Rissman

Best Publications

• Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.

  Peter T. Nelson;Dennis W. Dickson;John Q. Trojanowski;Clifford R. Jack

  1454
  Citations

• Functional Amyloids as Natural Storage of Peptide Hormones in Pituitary Secretory Granules

  Samir K. Maji;Marilyn H. Perrin;Michael R. Sawaya;Sebastian Jessberger

  1171
  Citations

• Brain cell type-specific enhancer-promoter interactome maps and disease-risk association.

  Alexi Nott;Inge R. Holtman;Inge R. Holtman;Nicole G. Coufal;Nicole G. Coufal;Johannes C. M. Schlachetzki

  746
  Citations

• A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease

  R. Scott Turner;Ronald G. Thomas;Suzanne Craft;Christopher H. van Dyck

  723
  Citations

• Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease.

  Charbel Moussa;Michaeline Hebron;Xu Huang;Jaeil Ahn

  665
  Citations

• Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology

  Robert A. Rissman;Wayne W. Poon;Mathew Blurton-Jones;Salvatore Oddo

  656
  Citations

• Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need

  Ganesh M. Babulal;Yakeel T. Quiroz;Benedict C. Albensi;Eider Arenaza-Urquijo

  506
  Citations

• The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

  Niklas Mattsson;Ulf Andreasson;Staffan Persson;Hiroyuki Arai

  452
  Citations

• Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology

  Unknown

  410
  Citations

• Urocortin Expression in Rat Brain: Evidence Against a Pervasive Relationship of Urocortin‐Containing Projections With Targets Bearing Type 2 CRF Receptors

  Jackson C. Bittencourt;Joan Vaughan;Carlos Arias;Robert A. Rissman

  399
  Citations

• Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile

  Charisse N. Winston;Edward J. Goetzl;Johnny C. Akers;Bob S. Carter

  394
  Citations

• CSF biomarker variability in the Alzheimer's Association quality control program

  Niklas Mattsson;Niklas Mattsson;Ulf Andreasson;Staffan Persson;Maria C. Carrillo

  393
  Citations

• The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer’s disease

  Ji-Yeun Hur;Georgia R. Frost;Georgia R. Frost;Xianzhong Wu;Christina Crump;Christina Crump

  367
  Citations

• Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial.

  Suzanne Craft;Rema Raman;Tiffany W. Chow;Michael S. Rafii

  345
  Citations

• Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain

  Troy T. Rohn;Robert A. Rissman;Michael C. Davis;Young Eun Kim

  320
  Citations

• Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic.

  Sid E. O'Bryant;Michelle M. Mielke;Robert A. Rissman;Simone Lista;Simone Lista

  295
  Citations

• Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change

  Unknown

  290
  Citations

• Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research

  Sid E. O'Bryant;Veer Gupta;Kim Henriksen;Melissa Edwards

  281
  Citations

• GABA(A) receptors in aging and Alzheimer's disease.

  Robert A. Rissman;Angel L. De Blas;David M. Armstrong

  259
  Citations

• The role of caspase cleavage of tau in Alzheimer disease neuropathology.

  Carl W. Cotman;Wayne W. Poon;Robert A. Rissman;Mathew Blurton-Jones

  250
  Citations